Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity

Carmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing · 2026

Read Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity by Carmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13255711.txt.

Description

Carmen Hannemann and co-authors report a 2026 laboratory study of iRhom2, a protein that helps macrophages release the inflammatory signal TNF-alpha. Macrophage-driven inflammation starts atherosclerosis, the plaque buildup behind heart attacks and strokes. The team studied macrophages lacking iRhom2 to see what changed.

The altered macrophages still engulfed particles, survived stress, and multiplied normally. They put out less TNF-alpha and more of the calming signal IL-10, though. Fluid from these cells also made blood vessel cells produce fewer of the sticky molecules that recruit more immune cells. The authors suggest blocking iRhom2 could quiet the earliest stage of vessel inflammation while leaving everyday macrophage duties intact, a profile that safer anti-inflammatory strategies would need.

Catalog record

CREATORCarmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13255711

Browse the full library · About the Tower of Babel